Refeyn is delighted to announce the appointment of Fiona Coats as Chief Marketing Officer, effective from June, 2024. Forming part of Refeyn’s executive team, Fiona will bring with her a wealth of experience from over 25 years in the biotechnology sector.
New US customer interaction center opens in Massachusetts’ Waltham Biotech Hub with 3rd annual Mass Photometry Summit set to highlight latest advances
New macro mass photometer can assess the stability, quality, and purity of adenovirus and lentivirus vectors within just minutes
Refeyn is pleased to announce the expansion of the consumables portfolio for mass photometry. Refeyn has created a new product line of mass reference standards, MassFerence, which help streamline sample characterization with mass photometry.
New microfluidic system enhances protein analysis workflows for the study of weak protein-protein interactions by mass photometry
Refeyn, a leading Life Science instrumentation company pioneering mass photometry, announced today that Gerry Mackay has been appointed the new CEO of the company effective January 1st, 2024.
New mass photometer characterizes AAV sample purity and empty/full ratio, with less manual operation time and greater reproducibility
Four years ago, at the Biophysical Society’s Annual Meeting 2018 in San Francisco, an early mass photometer made its first public appearance, when a University of Oxford team led by Philipp Kukura and Daniel Cole brought a prototype to demonstrate live in the BPS exhibition hall.
New compact mass photometer enables rapid analysis of empty/full AAV capsid ratios at the bench
